Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

22.15 +0.02 (+0.09%)
Streaming Delayed Price Updated: 9:34 AM EDT, Jul 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Activist Investor Starboard Acquires Stake In Band-Aid Maker Kenvue, Shares Jump
Activist hedge fund Starboard Value has reportedly taken a stake in Kenvue, sparking a pre-market stock surge. 
Via Talk Markets
Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff?
Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc, the company behind popular consumer products like Tylenol and Listerine. 
Via Benzinga
Kenvue to Announce Third Quarter 2024 Results on November 7, 2024
From Kenvue
Via Business Wire
Kenvue Declares Quarterly Cash Dividend
From Kenvue
Via Business Wire
Johnson & Johnson Stock: Setting the Stage for 2025 Highs
Healthcare giant and Dividend Aristocrat Johnson & Johnson is on track to hit new highs in 2025 and may sustain its rally well into 2026. 
Via MarketBeat
Navigating 10 Analyst Ratings For Kenvue
Via Benzinga
P/E Ratio Insights for Kenvue
Via Benzinga
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year
Target, PepsiCo, and Kenvue have high yields and inexpensive valuations. 
Via The Motley Fool
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Sanofi is negotiating a potential sale of a 50% stake in its consumer health unit, Opella, to Clayton Dubilier & Rice. The deal, valued at $16.4 billion, could help Sanofi sharpen its focus on... 
Via Benzinga
There are signs that NYSE:KVUE may be ready to breakout.
KENVUE INC is setting up nicely for a breakout. 
Via Chartmill
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Sanofi plans to spin off its consumer healthcare division, which could be valued at over $16.8 billion. Private equity firms are bidding for the unit, with the spinoff expected by Q4 2024. Banks... 
Via Benzinga
Analyst Ratings For Kenvue
Via Benzinga
Decoding 5 Analyst Evaluations For Kenvue
Via Benzinga
Kenvue Drives Climate Action Strategy Forward
From Kenvue
Via Business Wire
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
Kenvue Inc., owner of major brands like Tylenol, is poised for a technical knockout with a Golden Cross pattern and legal win. 
Via Benzinga
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
Via The Motley Fool
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets. 
Via Benzinga
Topics Stocks
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
Kenvue defends against a consumer lawsuit alleging that its Tylenol "Rapid Release" gelcaps did not relieve pain faster than regular tablets. A federal judge ruled the claims were preempted by FDA... 
Via Benzinga
Topics Lawsuit
Donald Trump Owns These 21 Dividend Kings. Should You?
Some of Trump's Dividend Kings deserve a crown more than others. 
Via The Motley Fool
Topics Government
Kenvue Announces Participation in the Barclays Global Consumer Staples Conference
From Kenvue
Via Business Wire
A Big CEO Move, Big Buffett Buys, and More
Motley Fool analysts talk over market news including earnings updates from Home Depot, Walmart, and Brinker. 
Via The Motley Fool
3 High-Yield Dividend ETFs to Buy to Generate Passive Income
ETFs offer a good way to own a diversified portfolio of income-producing equities. 
Via The Motley Fool
Topics ETFs
Lock in Gains: 3 Dividend Stocks Poised to Boost Payouts Soon
These three stocks have a long history of increasing their dividends and are likely to benefit from sector rotation on expectations of lower interest rates 
Via MarketBeat
Topics Artificial Intelligence Economy
7 Stable Dividend Stocks to Scoop Up on Discount
The market is looking shaky. To help calm your nerves and sleep easier at night, consider adding these stable dividend stocks to your holdings. 
Via InvestorPlace
Shopify, Palantir And Uber Are Among Top 10 Large Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
Top 10 best performing large-cap stocks last week: Shopify, Palantir, Axon, Fortinet, Trade Desk, Natera, SharkNinja, Zillow, Aspen Tech, Uber. 
Via Benzinga
2 Healthcare Stocks to Buy Hand Over Fist in August
These longtime winners still have a lot to offer. 
Via The Motley Fool
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture. 
Via Talk Markets
Topics Stocks
The 7 Best Under $20 Stocks to Buy in August 2024
Although cheap stocks are often cheap for a reason, it doesn't hold true for the best stocks under $20, which is where investors can profit. 
Via InvestorPlace
Kenvue (KVUE) Q2 2024 Earnings Call Transcript
KVUE earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Kenvue News: Why Investors Are Loving KVUE Stock This Week
Kenvue investors are seeing a nice 14% pop in KVUE stock today, after the company reported second quarter earnings that beat on both lines. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.